AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...
KL Krems & MedUni Vienna study provides new insights into the genetic mechanisms of birch pollen allergy: Krems, Austria Friday, January 17, 2025, 16:00 Hrs [IST] An innovative st ...